Late Breaking Abstract - Clinical remission with mepolizumab in severe asthma: impact of lung function parameters

被引：1
|
作者：
Oppenheimer, John [1 ]
Carrillo Diaz, Teresa [2 ]
Martinez Moragon, Eva [3 ]
Sanchez Herrero, M. Guadalupe [4 ]
Banas Conejero, David [4 ]
Chupp, Geoffrey [5 ]
Price, Robert G. [6 ]
Raimondi, Alejandro [7 ]
Zhang, Shiyuan [8 ]
Howarth, Peter [9 ]
Domingo Ribas, Christian [10 ]
机构：
[1] Rutgers New Jersey Med Sch, Newark, NJ USA
[2] Univ Las Palmas Gran Canaria, Las Palmas Gran Canaria, Spain
[3] Hosp Univ Dr Peset, Valencia, Spain
[4] GSK, Madrid, Spain
[5] Yale Sch Med, New Haven, CT USA
[6] GSK, Stevenage, Herts, England
[7] GSK, Buenos Aires, DF, Argentina
[8] GSK, Collegeville, PA USA
[9] GSK, Brentford, England
[10] Univ Autonoma Barcelona, Barcelona, Spain
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA646
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA646
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Late-breaking abstract: A phase 2 study of benralizumab on exacerbations, lung function, and asthma control in adults with uncontrolled eosinophilic asthma
    Castro, Mario
    Wenzel, Sally
    Kolbeck, Roland
    Khatry, Deepak
    Christine, Ward
    Wu, Yanping
    van der Merwe, Rene
    Bleecker, Eugene
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [32] LATE-BREAKING ABSTRACT: Clinical characteristics of four endophenotypic clusters of smokers with preserved lung function
    Li, Xingnan
    Han, MeiLan
    Ortega, Victor
    Dransfield, Mark
    Li, Huashi
    Barr, Graham
    Couper, David
    Hoffman, Eric
    Kanner, Richard
    Kleerup, Eric
    Martinez, Fernando
    Woodruff, Prescott
    Meyers, Deborah
    Bleecker, Eugene
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [33] Effect of add-on therapies (mepolizumab, omalizumab or azithromycin) on asthma remission in severe asthma
    Thomas, Dennis
    Mcdonald, Vanessa
    Stevens, Sean
    Harvey, Erin
    Baraket, Melissa
    Bardin, Philip
    Bowden, Jeff
    Bowler, Simon
    Chien, Jimmy
    Chung, Li Ping
    Gillman, Andrew
    Hew, Mark
    Hodge, Sandra
    James, Alan
    Jenkins, Christine
    Katelaris, Constance
    Katsoulotos, Gregory
    Langton, David
    Lee, Joy
    Marks, Guy
    Peters, Matthew
    Radhakrishna, Naghmeh
    Reynolds, Paul
    Rimmer, Janet
    Sivakumaran, Pathmanathan
    Upham, John
    Wark, Peter
    Yang, Ian
    Gibson, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [34] Late Breaking Abstract - Longitudinal analysis of variation in clinical features from the U-BIOPRED severe asthma cohort
    Shaw, Dominick
    Bansal, Aruna T.
    Riley, John
    Bates, Stewart
    Pavlidis, Stelios
    Fleming, Louise J.
    Adcock, Ian M.
    Corfield, Julie
    Auffray, Charles
    Bigler, Jeanette
    Bisgaard, Hans
    Boedigheimer, Michael
    Bonnelykke, Klaus
    Bush, Andrew
    Chung, Kian Fan
    Djukanovic, Ratko
    Frey, Urs
    Fowler, Stephen J.
    Hashimoto, Simone
    Hedlin, Gunila
    Hu, Xuguang
    Murray, Claire
    Nordlund, Bjorn
    Singer, Florian
    Sterk, Peter J.
    Sousa, Ana R.
    Van Aalderen, Wim
    Wagers, Scott
    Yu, Wen
    Roberts, Graham
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [35] Impact of baseline characteristics on clinical remission achievement in severe asthma
    Domingo Ribas, C.
    Pavord, I
    Banas Conejero, D.
    Price, R. G.
    Pullan, A.
    Oppenheimer, J.
    Heaney, L. G.
    Nagase, H.
    Pizzichini, E.
    Howarth, P.
    Gardiner, F.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [36] Late Breaking Abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
    Pavord, Ian Douglas
    Kerstjens, Huib A. M.
    Korn, Stephanie
    Criner, Gerard J.
    Sagara, Hironori
    Rubin, David B.
    Harris, Stephanie Schweiker
    Mayer, Bhabita
    Bradford, Eric S.
    Albers, Frank C.
    Yancey, Steven W.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [37] Time is lung: higher preservation of lung function in severe asthma patients after earlier mepolizumab treatment
    Gonzalez-Barcala, Francisco-Javier
    Bobolea, Irina
    Dominguez-Ortega, Javier
    Banas-Conejero, David
    Antelo-Cea, Esteban
    Martinez-Moragon, Eva
    Carrillo-Diaz, Teresa
    Blanco-Aparicio, Marina
    Domingo, Christian
    ERJ OPEN RESEARCH, 2025, 11 (01)
  • [38] Late Breaking Abstract - Effectiveness and safety of mepolizumab in real-world clinical practice: the REALITI-A study
    Harrison, Tim
    Canonica, G. Walter
    Gemzoe, Kim
    Maxwell, Aoife
    Yang, Shibing
    Joksaite, Sandra
    O'Reilly, Ronan
    Van Dyke, Melissa
    Albers, Frank C.
    Kwon, Namhee
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [39] Impact of Mepolizumab on Airway Remodelling in Severe Eosinophilic Asthma
    Taille, C.
    Hamidi, F.
    Heddebaut, N.
    Dupin, C.
    Le Guen, P.
    Le Brun, M.
    Pote, N.
    Cazes, A.
    Roy, C.
    Dupont, A.
    Letuve, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [40] Impact of age on the efficacy of mepolizumab in severe uncontrolled asthma
    Gonzalez Barcala, Francisco-Javier
    Blanco-Aparicio, Marina
    Nieto-Fontarigo, Juan-Jose
    Blanco-Cid, Nagore
    Gonzalez-Fernandez, Coral
    Mosteiro-Anon, Mar
    Calvo-Alvarez, Uxio
    Perez-De-Llano, Luis
    Corbacho-Abelaira, Maria-Dolores
    Dominguez-Juncal, Luis
    Crespo-Diz, Carlos
    Dacal-Quintas, Raquel
    Pallares-Sanmartin, Abel
    Dacal-Rivas, David
    Ruiz-Ferreras, Raquel
    Salgado, Francisco-Javier
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
12345